Alberto Sobrero
Impact in
- Oncology top 0.1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 169
- Colorectal Cancer Treatments and Studies 145
- Cancer Treatment and Pharmacology 58
- Colorectal Cancer Surgical Treatments 18
- Pancreatic and Hepatic Oncology Research 13
-
- Gastric Cancer Management and Outcomes 43
- Lung Cancer Treatments and Mutations 29
- Co-authors
- Eric Van Cutsem (45 shared papers)Josep Tabernero (31 shared papers)C. Aschele (22 shared papers)Joseph R. Bertino (18 shared papers)Marc Ychou (12 shared papers)Daniel J. Sargent (13 shared papers)Heinz‐Josef Lenz (13 shared papers)Salvatore Siena (17 shared papers)
- Journals
- Journal of Clinical Oncology (54 papers)Annals of Oncology (29 papers)European Journal of Cancer (19 papers)British Journal of Cancer (8 papers)Clinical Colorectal Cancer (5 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Alberto Sobrero
200 papers receiving 11.9k citations
Alberto Sobrero's Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 7.8k
- Hepatology 2.0k
- Pathology and Forensic Medicine 1.6k
- Pulmonary and Respiratory Medicine 2.5k
- Cancer Research 1.1k
Countries citing papers authored by Alberto Sobrero
This map shows the geographic impact of Alberto Sobrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Sobrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Sobrero more than expected).
Fields of papers citing papers by Alberto Sobrero
This network shows the impact of papers produced by Alberto Sobrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Sobrero. The network helps show where Alberto Sobrero may publish in the future.
Co-authors
The 25 scholars most cited alongside Alberto Sobrero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2012 | 2091 |
| 2 | Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2010 | 756 |
| 3 | EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 728 |
| 4 | A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) Hit paper breakdown → | 2015 | 542 |
| 5 | 2009 | 486 | |
| 6 | 2004 | 419 | |
| 7 | The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus Hit paper breakdown → | 2012 | 392 |
| 8 | Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus Hit paper breakdown → | 2015 | 386 |
| 9 | 2004 | 313 | |
| 10 | 2009 | 300 | |
| 11 | 2007 | 284 | |
| 12 | 1997 | 276 | |
| 13 | 2007 | 262 | |
| 14 | 2009 | 257 | |
| 15 | 2015 | 232 | |
| 16 | 2007 | 186 | |
| 17 | 1999 | 171 | |
| 18 | 2012 | 165 | |
| 19 | Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. | 1992 | 161 |
| 20 | 2013 | 159 |
About Alberto Sobrero
Alberto Sobrero is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Hepatology and Cancer Research, having authored 208 papers that have together received 12.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (145 papers), Cancer Treatment and Pharmacology (58 papers), Gastric Cancer Management and Outcomes (43 papers), Genetic factors in colorectal cancer (30 papers), Lung Cancer Treatments and Mutations (29 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Colorectal Cancer Surgical Treatments (18 papers) and Pancreatic and Hepatic Oncology Research (13 papers). The work is most often cited by research in Oncology (7.8k citations), Hepatology (2.0k citations), Pathology and Forensic Medicine (1.6k citations), Pulmonary and Respiratory Medicine (2.5k citations) and Cancer Research (1.1k citations). Alberto Sobrero has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Eric Van Cutsem, Josep Tabernero, C. Aschele, Joseph R. Bertino, Marc Ychou, Daniel J. Sargent, Heinz‐Josef Lenz, Salvatore Siena, Axel Grothey and Richard M. Goldberg. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, British Journal of Cancer and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.